BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/25/2024 10:27:30 AM | Browse: 146 | Download: 845
 |
Received |
|
2024-04-23 01:20 |
|
Peer-Review Started |
|
2024-04-23 01:20 |
|
First Decision by Editorial Office Director |
|
2024-08-01 21:05 |
|
Return for Revision |
|
2024-08-02 00:31 |
|
Revised |
|
2024-08-13 14:23 |
|
Publication Fee Transferred |
|
2024-09-16 13:58 |
|
Second Decision by Editor |
|
2024-09-10 02:47 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-10 07:32 |
|
Articles in Press |
|
2024-09-10 07:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-26 00:38 |
|
Publish the Manuscript Online |
|
2024-10-25 10:27 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shu-Liang Li, Pei-Yao Wang, Yang-Pu Jia, Zhao-Xiong Zhang, Hao-Yu He, Peng-Yu Chen, Xin Liu, Bang Liu, Li Lu and Wei-Hua Fu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Tianjin Municipal Education Commission Scientific Research Project |
No. 2018KJ055 |
|
| Corresponding Author |
Wei-Hua Fu, MD, PhD, Professor, Surgeon, Teacher, Department of General Surgery, Tianjin Medical University General Hospital, Tianjin Medical University, No. 154 Anshan Road, Tianjin 300052, China. tjmughgs_fwh@163.com |
| Key Words |
Gastric cancer; Human epidermal growth factor receptor 2; Trastuzumab; Drug-resistance; BIRC3 |
| Core Tip |
Our study discovered that the overexpression of BIRC3 leads to the stimulation of phosphoinositide 3-kinase-Akt phosphorylation and activation. Consequently, this enhances the proliferation of human epidermal growth factor receptor 2-positive tumor cells and inhibits apoptosis, resulting in resistance to trastuzumab. |
| Publish Date |
2024-10-25 10:27 |
| Citation |
Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH. BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 2024; 16(11): 4436-4455 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i11/4436.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i11.4436 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
